LOGIN
Reduction in PGE2 Levels with Photobiomodulation Therapy vs Sham for Non-Specific Low Back Pain
March 2021
Reduction in PGE2 Levels with Photobiomodulation Therapy vs Sham for Non-Specific Low Back Pain
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Photobiomodulation Therapy is Able to Modulate PGE 2 Levels in Patients With Chronic Non-Specific Low Back Pain: A Randomized Placebo-Controlled Trial
Lasers Surg Med. 2021 Feb;53(2): 236-244.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Eighteen patients with chronic non-specific low back pain were randomized to receive a single session of photobiomodulation therapy (n=9) or sham therapy (n=9) for the modulation of inflammatory markers and relief of pain. The primary outcome of interest was prostaglandin E2 (PGE2) levels. Secondary outcomes of interest included tumour necrosis factor alpha (TNF-a), interleukin (IL)-6 levels, and ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.